SOUTH SAN FRANCISCO, CA: Results Detail the Discovery of Potent Nucleoside Analogs That Inhibit RSV Replication The Company Is on Track for Initiating Clinical Development of ALS-8176, a Potent Orally Bioavailable Nucleoside ...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.